XM tillhandahåller inte tjänster till personer bosatta i USA.

Foreign investors struggle to keep up with India's rise



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>RPT-ANALYSIS-Foreign investors struggle to keep up with India's rise</title></head><body>

Repeats story from Thursday.

India surges toward leading position on EM benchmark

Mid and large stocks have highest PE ratio globally - LSEG

Funds shy of buying deepen underweight allocation

By Ankur Banerjee

SINGAPORE, Sept 5 (Reuters) -India's stock market rally is ramping up its index weighting and creating a dilemma for global fund managers: sit back and watch as their relative exposure shrinks while the market grows, or buy in at increasingly eye-watering prices.

Most find the latter uncomfortably risky and are seeking alternatives, some driving money into India's smaller companies, while others are looking elsewhere at other emerging markets.

The trend has been driven by years of strong earnings in India at the same time as China's markets have stumbled, upending their weightings in the MSCI Emerging Markets' Index .MSCIEF which serves as a benchmark for global EM funds.

India's MSCI EM weight has shot to 19%, up from just 8% four years ago and analysts at Nuvama Alternative & Quantitative Research expect it to top 22% by the end of this year. China's weighting over the same period has collapsed from 40% to 25%, data from MSCI shows.

"The convergence between India and China is causing problems for a lot of portfolio managers because if you had a global mandate or a pan-Asia mandate, you probably were at best equal weight India and probably underweight," said Vikas Pershad, portfolio manager for Asian equities at M&G Investments.

"And that underweight is growing."

Part of the reason for the long-term underweight has been that many investors preferred China's cheaper and dynamic market, while entry and exit costs for funds can be high in India.

Managers would need to buy Indian companies at a rapid clip to keep up with their increasing presence in indexes, which with an average 12-month price-to-earnings ratio of 24 times for big and middle-sized firms are the most expensive in major markets, according to LSEG data.

Many are choosing not to do so, leaving India the biggest underweight allocation among emerging market funds, according to HSBC and Copley Fund Research.

Valuations for Chinese blue chips .CSI300, by contrast, are far lower with the same price-to-earnings measure at 17 and at 15 for big Malaysian stocks .KLSE.

For Gary Tan, portfolio manager at Allspring Global Investments, and his clients, valuations are the sticking point.

"We are optimistic on the long-term story, but really cautious on where valuations are," said Tan, who has been underweight India for the last couple of years.


NO SECRET

Valuations have long been relatively high in India and no barrier to outperformance. Now, however, some investors are becoming wary of the risk-reward balance.

India's Nifty 50 index .NSEI has risen 145% and the S&P BSE Sensex .BSESN has surged 136% since mid-2020, while the S&P 500 .SPX in the same period has gained 78% and China's blue-chip index .CSI300 has slid 22%.

Yet while foreigners have been consistent buyers of Indian stocks this year and in 2023, the flow and sentiment is beginning to shift.

ICICI Securities data shows foreign buying over the first half of this year has been much higher in small to mid size firms than in large caps and in August, exchange data showed foreigners turned sellers of $662 million in shares.

Foreign investors account for roughly 16% of total Indian stocks holding, according to ICICI Securities, the lowest in a decade.

To be sure, there are plenty of bulls and money that isn't benchmarked to emerging markets' indexes that is flowing in.

Howie Schwab, portfolio manager for emerging markets growth at Driehaus Capital, said there's an increased interest from global investors in India, not just from those with emerging markets mandates.

Vivian Lin Thurston, portfolio manager for William Blair's emerging markets growth strategy, says valuation alone is not necessarily reason enough to look elsewhere.

"Do I have another attractive opportunity set to put money in if I take down India, the answer is not many at present, and this is a factor I'm struggling with, or grappling with," she said.

However flows into Malaysia and Indonesia, where markets are on a tear, point to investors looking further afield, for now.

"India's economic growth story is not a secret," said James Cook, investment director for global emerging markets at U.S. fund manager Federated Hermes, who is underweight India and waiting for prices to fall before buying any further.

"When you have such a consensus, and the outlook appears to be benign, investors can fall into a trap, blind to any potential pitfalls, such as paying too high a price to participate."



Reporting by Ankur Banerjee in Singapore, additional reporting by Gaurav Dogra and Bharath Rajeswaran in Bengaluru; editing by Tom Westbrook and Shri Navaratnam

</body></html>

Ansvarsfriskrivning: XM Group-enheter tillhandahåller sin tjänst enbart för exekvering och tillgången till vår onlinehandelsplattform, som innebär att en person kan se och/eller använda tillgängligt innehåll på eller via webbplatsen, påverkar eller utökar inte detta, vilket inte heller varit avsikten. Denna tillgång och användning omfattas alltid av i) villkor, ii) riskvarningar och iii) fullständig ansvarsfriskrivning. Detta innehåll tillhandahålls därför uteslutande som allmän information. Var framför allt medveten om att innehållet på vår onlinehandelsplattform varken utgör en uppmaning eller ett erbjudande om att ingå några transaktioner på de finansiella marknaderna. Handel på alla finansiella marknader involverar en betydande risk för ditt kapital.

Allt material som publiceras på denna sida är enbart avsett för utbildnings- eller informationssyften och innehåller inte – och ska inte heller anses innehålla – rådgivning och rekommendationer om finansiella frågor, investeringsskatt eller handel, dokumentation av våra handelskurser eller ett erbjudande om, eller en uppmaning till, en transaktion i finansiella instrument eller oönskade finansiella erbjudanden som är riktade till dig.

Tredjepartsinnehåll, liksom innehåll framtaget av XM såsom synpunkter, nyheter, forskningsrön, analyser, kurser, andra uppgifter eller länkar till tredjepartssajter som återfinns på denna webbplats, tillhandahålls i befintligt skick, som allmän marknadskommentar, och utgör ingen investeringsrådgivning. I den mån som något innehåll tolkas som investeringsforskning måste det noteras och accepteras att innehållet varken har varit avsett som oberoende investeringsforskning eller har utarbetats i enlighet med de rättsliga kraven för att främja ett sådant syfte, och därför är att betrakta som marknadskommunikation enligt tillämpliga lagar och föreskrifter. Se till så att du har läst och förstått vårt meddelande om icke-oberoende investeringsforskning och riskvarning om ovannämnda information, som finns här.

Riskvarning: Ditt kapital riskeras. Hävstångsprodukter passar kanske inte alla. Se vår riskinformation.